Literature DB >> 144457

In vitro activity of spectinomycin against recent urinary tract isolates.

R J Fass, R B Prior.   

Abstract

The susceptibilities to spectinomycin of 303 recent urinary tract isolates were determined and compared to the susceptibilities of those strains to ampicillin, tetracycline, and gentamicin. Based on minimal inhibitory concentrations, 84% of Escherichia coli, Klebsiella, and Enterobacter, 31% of other Enterobacteriaceae, 7% of Staphylococcus aureus and Streptococcus (including enterococci), and 0% of Pseudomonas aeruginosa were susceptible to concentrations of spectinomycin that are easily surpassed in serum (</=32 mug/ml); 90% of all organisms tested other than P. aeruginosa were susceptible to concentrations that are easily surpassed in urine (</=128 mug/ml). Spectinomycin was active against more isolates than either ampicillin or tetracycline but against fewer isolates than gentamicin. Disk diffusion susceptibility tests did not reliably distinguish susceptible from resistant isolates with any of the four antibiotics studied.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 144457      PMCID: PMC429967          DOI: 10.1128/AAC.12.4.551

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  EVALUATION OF ACTINOSPECTACIN IN URINARY TRACT INFECTIONS.

Authors:  J P VINEYARD; B M MAYS; J P SANFORD
Journal:  Clin Pharmacol Ther       Date:  1963 Sep-Oct       Impact factor: 6.875

2.  THE LOCALIZATION AND TREATMENT OF URINARY TRACT INFECTIONS: THE ROLE OF BACTERICIDAL URINE LEVELS AS OPPOSED TO SERUM LEVELS.

Authors:  T A STAMEY; D E GOVAN; J M PALMER
Journal:  Medicine (Baltimore)       Date:  1965-01       Impact factor: 1.889

3.  An evaluation of a new antibiotic, actinospectacin, in infections of the urinary tract.

Authors:  R I LINDEMEYER; M TURCK; R G PETERSDORF
Journal:  Am J Med Sci       Date:  1962-10       Impact factor: 2.378

4.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

5.  Animal and human tolerance of high-dose intramuscular therapy with spectinomycin.

Authors:  E Novak; J E Gray; R T Pfeifer
Journal:  J Infect Dis       Date:  1974-07       Impact factor: 5.226

6.  The tolerance of high dose intravenous spectinomycin therapy in man.

Authors:  E Novak; C A Schlagel; L A LeZotte; R T Pfeifer
Journal:  J Clin Pharmacol       Date:  1974 Aug-Sep       Impact factor: 3.126

7.  Interaction of clindamycin and gentamicin in vitro.

Authors:  R J Fass; C A Rotilie; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

8.  In vitro antibacterial activity of spectinomycin.

Authors:  I I Washington JA; P K Yu
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

9.  Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas.

Authors:  W Karney; K K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

Review 10.  Drugs five years later. Spectinomycin.

Authors:  W M McCormack; M Finland
Journal:  Ann Intern Med       Date:  1976-06       Impact factor: 25.391

View more
  1 in total

1.  Derivatives of 4-dihydro-4-deoxy-4(R)-amino spectinomycin and their activity against susceptible and resistant Escherichia coli strains.

Authors:  R G Werner; U L Lechner; H Goeth
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.